Not exact matches
Pfizer's Celebrex fared well in a
safety study that compared the
pain reliever with ibuprofen and naproxen.
As part of the Cannabis for the Management of
Pain: Assessment of
Safety Study (COMPASS), that started in 2004, the researchers followed 215 adult patients, with chronic non-cancer
pain, who used medical cannabis, and compared them to a control group of 216 chronic
pain sufferers who were not cannabis users.
«Multicenter
study examines
safety of medical cannabis in treatment of chronic
pain.»
A Canadian research team led by Dr. Mark Ware from the Research Institute of the McGill University Health Centre (RI - MUHC) in Montréal has completed a national multicentre
study looking at the
safety of medical cannabis use among patients suffering from chronic
pain.
A landmark 2016 Cleveland Clinic
study of widely used
pain - relieving drugs showed that celecoxib (Celebrex) was associated with comparable cardiovascular
safety and better gastrointestinal (GI) and kidney
safety when compared...
«IKKs are one of the most heavily sought after drug targets today, because pharmaceutical companies want safe and effective medications to treat the
pain of arthritis, now that the
safety of COX - 2 inhibitors, like Celebrex and Vioxx, have been called into question,» says Salk researcher Vinay Tergaonkar who was involved in the zebrafish
study.
There is a shortage of high - quality evidence demonstrating the
safety and effectiveness of long - term opioid therapy for the management of chronic
pain, and to date, no large - scale
studies have assessed strategies for managing and reducing chronic opioid use in real - world clinical settings.
A randomized, blinded, placebo - controlled pivotal field
study to evaluate the effectiveness and
safety of robenacoxib (tablets) when administered at a dose of 2 mg / kg once daily for 3 days for the control of postoperative
pain and inflammation associated with soft - tissue surgery in dogs.
In two large clinical
studies, SIMBADOL (buprenorphine injection) was well tolerated and demonstrated
safety and efficacy for post operative
pain control in cats.2
Gabapentin may play a role in chronic
pain management in pets; however further research and
studies need to be done on efficacy and
safety.
Symptoms of Bladder Cancer: • Blood in the urine • Straining or
pain during urination • Urinating often • Incontinence • Fatigue • Bone tenderness •
Pain • Weight loss FDA Drug
Safety Communication: Update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case - control study, British Medical Journal, May 31
Safety Communication: Update to ongoing
safety review of Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case - control study, British Medical Journal, May 31
safety review of Actos (pioglitazone) and increased risk of bladder cancer, FDA, June 15, 2011 The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case - control
study, British Medical Journal, May 31, 2012
In the present
study, we explored the psychological and neural underpinnings of attachment - induced
safety by examining whether viewing an attachment figure during a threatening experience — receiving physical
pain — led to increased activity in a neural region associated with
safety signaling and a corresponding reduction in the threatening or distressing experience of physical
pain.